CSBR
CHAMPIONS ONCOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$5.15
+1.28%Next report
Analyst consensus
- Next report date
- Dec 15, 2026
- EPS estimate
- $0.02
- Revenue estimate
- $16.4M
Latest reported
- Last report date
- Sep 10, 2026
- EPS actual
- $0.05
- EPS estimate
- -$0.01
- Revenue actual
- $15.2M
- Revenue estimate
- $15.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +0.7%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 10, 2026 | -$0.01 | $0.05 | Beat 600.00% | $15.2M |
| Mar 12, 2026 | $0.09 | -$0.02 | Miss -122.22% | $16.6M |
| Dec 15, 2025 | $0.08 | $0.02 | Miss -75.00% | $15.0M |
| Sep 15, 2025 | $0.01 | -$0.03 | Miss -400.00% | $14.0M |
| Mar 11, 2025 | -$0.01 | $0.31 | Beat 3200.00% | $17.0M |
| Dec 11, 2024 | $0.01 | $0.05 | Beat 400.00% | $13.5M |
| Sep 11, 2024 | $0.02 | $0.11 | Beat 466.72% | $14.1M |
| Mar 12, 2024 | -$0.06 | -$0.19 | Miss -216.67% | $12.0M |
| Dec 12, 2023 | -$0.17 | -$0.15 | Beat 11.76% | $11.6M |
| Sep 13, 2023 | -$0.10 | -$0.19 | Miss -90.00% | $12.6M |
| Mar 15, 2023 | -$0.06 | -$0.18 | Miss -200.00% | $12.8M |
| Dec 13, 2022 | -$0.00 | -$0.00 | Miss -100.00% | $14.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 15, 2026